WO2006031856A2 - Biosynchronous transdermal drug delivery - Google Patents
Biosynchronous transdermal drug delivery Download PDFInfo
- Publication number
- WO2006031856A2 WO2006031856A2 PCT/US2005/032672 US2005032672W WO2006031856A2 WO 2006031856 A2 WO2006031856 A2 WO 2006031856A2 US 2005032672 W US2005032672 W US 2005032672W WO 2006031856 A2 WO2006031856 A2 WO 2006031856A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug
- animal
- human
- time
- timing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0266—Shape memory materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3337—Controlling, regulating pressure or flow by means of a valve by-passing a pump
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrotherapy Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007531458A JP5254616B2 (en) | 2004-09-13 | 2005-09-13 | Biosynchronous transdermal drug delivery |
AU2005284908A AU2005284908B2 (en) | 2004-09-13 | 2005-09-13 | Biosynchronous transdermal drug delivery |
CA2580329A CA2580329C (en) | 2004-09-13 | 2005-09-13 | Biosynchronous transdermal drug delivery |
EP05796698.8A EP1802258A4 (en) | 2004-09-13 | 2005-09-13 | Biosynchronous transdermal drug delivery |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60941804P | 2004-09-13 | 2004-09-13 | |
US60/609,418 | 2004-09-13 | ||
US11/162,517 | 2005-09-13 | ||
US11/162,517 US20070191815A1 (en) | 2004-09-13 | 2005-09-13 | Biosynchronous transdermal drug delivery |
US11/162,525 US7780981B2 (en) | 2004-09-13 | 2005-09-13 | Biosynchronous transdermal drug delivery |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006031856A2 true WO2006031856A2 (en) | 2006-03-23 |
WO2006031856A3 WO2006031856A3 (en) | 2006-08-17 |
Family
ID=38024536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/032672 WO2006031856A2 (en) | 2004-09-13 | 2005-09-13 | Biosynchronous transdermal drug delivery |
Country Status (6)
Country | Link |
---|---|
US (10) | US7780981B2 (en) |
EP (1) | EP1802258A4 (en) |
JP (1) | JP5254616B2 (en) |
AU (1) | AU2005284908B2 (en) |
CA (1) | CA2580329C (en) |
WO (1) | WO2006031856A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009076363A1 (en) * | 2007-12-10 | 2009-06-18 | Isis Biopolymer Llc | Iontophoretic drug delivery device and software application |
DE102010030502A1 (en) | 2010-06-24 | 2011-12-29 | HSG-IMIT-Institut für Mikro- und Informationstechnologie | Quellstoffaktor and conveyor, in particular for a medicinal active substance |
WO2013136176A1 (en) * | 2012-03-13 | 2013-09-19 | Becton Dickinson France | Injection device having a miniaturized drug delivery portion |
WO2017019526A2 (en) | 2015-07-24 | 2017-02-02 | Kimberly-Clark Worldwide, Inc. | Methods for better delivery of active agents to tumors |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100260669A1 (en) * | 2004-05-13 | 2010-10-14 | Anthony Joonkyoo Yun | Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System |
EP1802258A4 (en) * | 2004-09-13 | 2015-09-23 | Chrono Therapeutics Inc | Biosynchronous transdermal drug delivery |
US8252321B2 (en) * | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
US7459469B2 (en) | 2004-11-10 | 2008-12-02 | Targacept, Inc. | Hydroxybenzoate salts of metanicotine compounds |
US20070042026A1 (en) * | 2005-03-17 | 2007-02-22 | Wille John J | Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions |
WO2006127905A2 (en) | 2005-05-24 | 2006-11-30 | Chrono Therapeutics, Inc. | Portable drug delivery device |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
TWI389889B (en) * | 2006-05-09 | 2013-03-21 | Targacept Inc | Novel polymorph forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine |
EP2357174A1 (en) * | 2006-05-09 | 2011-08-17 | AstraZeneca AB | Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine |
US20090264814A1 (en) * | 2006-08-02 | 2009-10-22 | Koninklijke Philips Electronics N.V. | Device for medical treatment decision support and/or monitoring the status of a patient |
CN101516255A (en) * | 2006-09-13 | 2009-08-26 | 皇家飞利浦电子股份有限公司 | Device for automatic adjustment of the dose of melatonin and/or delivery of melatonin |
US20080107719A1 (en) * | 2006-11-08 | 2008-05-08 | Sukhon Likitlersuang | Transdermal drug delivery system |
US20080152709A1 (en) * | 2006-12-22 | 2008-06-26 | Drugtech Corporation | Clonidine composition and method of use |
WO2008091588A1 (en) * | 2007-01-22 | 2008-07-31 | Targacept, Inc. | Intranasal, buccal, and sublingual administration of metanicotine analogs |
US7715679B2 (en) | 2007-05-07 | 2010-05-11 | Adc Telecommunications, Inc. | Fiber optic enclosure with external cable spool |
MX337286B (en) | 2007-05-25 | 2016-02-22 | Indivior Uk Ltd | Sustained delivery formulations of risperidone compounds. |
AU2008282205A1 (en) * | 2007-07-31 | 2009-02-05 | Astrazeneca Ab | Transdermal administration of (2S)-(4E)-N-methyl-5-(3-( 5-isopropoxypyridin)yl)-4-penten-2-amine |
EP2178598A4 (en) * | 2007-08-17 | 2012-08-15 | Isis Biopolymer Llc | Iontophoretic drug delivery system |
US20100121307A1 (en) * | 2007-08-24 | 2010-05-13 | Microfabrica Inc. | Microneedles, Microneedle Arrays, Methods for Making, and Transdermal and/or Intradermal Applications |
EP2141620B1 (en) * | 2008-07-01 | 2018-10-31 | Roche Diabetes Care GmbH | Insulin pump and method for controlling a user interface of an insulin pump |
US20100163029A1 (en) | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method for administering an inhalable compound |
US20100169260A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc | Methods and systems for presenting an inhalation experience |
WO2010120892A2 (en) * | 2009-04-14 | 2010-10-21 | The Regents Of The University Of California | Improved oral drug devices and drug formulations |
US20110092881A1 (en) * | 2009-05-08 | 2011-04-21 | Isis Biopolymer Inc. | Iontophoretic device with contact sensor |
SG175341A1 (en) * | 2009-05-08 | 2011-11-28 | Isis Biopolymer Inc | Iontophoretic device with improved counterelectrode |
EP2724739B1 (en) | 2009-07-30 | 2015-07-01 | Tandem Diabetes Care, Inc. | Portable infusion pump system |
BR112012029326A2 (en) | 2010-05-20 | 2017-08-08 | Astrazeneca Ab | process for the preparation of aryl-substituted olefinic animals |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
US8623409B1 (en) | 2010-10-20 | 2014-01-07 | Tris Pharma Inc. | Clonidine formulation |
CA2841785A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
US9539201B2 (en) | 2012-04-20 | 2017-01-10 | KAT Transdermals LLC | Selegiline transdermal system |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
US20140207047A1 (en) * | 2013-01-22 | 2014-07-24 | Chrono Therapeutics, Inc. | Transdermal drug delivery system and method |
US10105487B2 (en) | 2013-01-24 | 2018-10-23 | Chrono Therapeutics Inc. | Optimized bio-synchronous bioactive agent delivery system |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
US10201656B2 (en) | 2013-03-13 | 2019-02-12 | Tandem Diabetes Care, Inc. | Simplified insulin pump for type II diabetics |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US9492608B2 (en) | 2013-03-15 | 2016-11-15 | Tandem Diabetes Care, Inc. | Method and device utilizing insulin delivery protocols |
EP3043860B1 (en) * | 2013-09-11 | 2019-05-22 | Incube Labs, Llc | System for controlling the iontophoretic delivery of therapeutic agents based on user inhalation |
FR3015300B1 (en) * | 2013-12-20 | 2018-03-02 | L'oreal | IONTOPHORESE DEVICE WITH TANK |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
AU2016211330A1 (en) | 2015-01-28 | 2017-08-03 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
US11147955B2 (en) | 2015-02-18 | 2021-10-19 | Alma Therapeutics Ltd. | Regulator device for drug patch |
US10004887B2 (en) | 2015-02-18 | 2018-06-26 | Alma Therapeutics Ltd. | Transdermal delivery assembly |
US10679516B2 (en) | 2015-03-12 | 2020-06-09 | Morningside Venture Investments Limited | Craving input and support system |
CA3016984A1 (en) * | 2015-04-17 | 2016-10-20 | Georgia Tech Research Corporation | Drug delivery device with housing and separable microneedles |
WO2017079761A1 (en) * | 2015-11-06 | 2017-05-11 | Bkr Ip Holdco Llc | Ultrasonic transducers suitable for ultrasonic drug delivery via a system, which is portable and wearable by the patient |
EP3386563B1 (en) | 2015-12-11 | 2019-10-16 | SeraIP AG | Fluid interface device for delivering fluid to and/or withdrawing fluid from a patient |
EP3416718A4 (en) | 2016-02-18 | 2020-03-11 | Alma Therapeuthics Ltd. | Regulator device for drug patch |
EP3321899A1 (en) * | 2016-11-10 | 2018-05-16 | Therasolve NV | Electronic communication unit for an adhesive patch |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
EP3801732A4 (en) | 2018-05-29 | 2022-04-27 | Morningside Venture Investments Limited | Drug delivery methods and systems |
CA3103274A1 (en) * | 2018-06-14 | 2019-12-19 | Anton SABIEV | Wireless iontophoresis patch and controller |
US11918689B1 (en) | 2020-07-28 | 2024-03-05 | Tris Pharma Inc | Liquid clonidine extended release composition |
WO2023276090A1 (en) * | 2021-06-30 | 2023-01-05 | シンクランド株式会社 | Transdermal administration apparatus and transdermal administration system |
WO2023108207A1 (en) * | 2021-12-17 | 2023-06-22 | Cosmoaesthetics Pty Ltd | A wearable transdermal drug applicator |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5538503A (en) * | 1993-09-15 | 1996-07-23 | Henley; Julian L. | Programmable apparatus for reducing substance dependency in transdermal drug delivery |
Family Cites Families (381)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2183482A (en) | 1936-12-23 | 1939-12-12 | Schmid Inc Julius | Injector |
US3279653A (en) | 1964-12-17 | 1966-10-18 | Frederick W Pfleger | Escapement controlled dispensing apparatus |
US3845217A (en) | 1972-11-16 | 1974-10-29 | Helsingborg L Ab | Buffered smoking substitute compositions |
GB1528391A (en) | 1976-01-05 | 1978-10-11 | Gildemeister V | Aerosol compositions |
GB2030862A (en) | 1978-04-10 | 1980-04-16 | Smith A | A composition for treating drug addiction such as smoking nicotine-containing products |
US4321387A (en) | 1980-03-21 | 1982-03-23 | Philip Morris, Incorporated | Process for the preparation of optically active nicotine analogs |
US4313439A (en) | 1980-03-24 | 1982-02-02 | Biotek, Inc. | Automated, spring-powered medicament infusion system |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4332945A (en) | 1981-01-29 | 1982-06-01 | Philip Morris, Incorporated | Optically active nicotine analogs and process for their preparation |
US4590278A (en) | 1981-01-29 | 1986-05-20 | Philip Morris Incorporated | Nicotine analogs |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
LU84485A1 (en) * | 1982-11-22 | 1984-06-13 | Oreal | NOVEL ANTI-ACNE COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE OTHER ACTIVE INGREDIENT |
GB8301659D0 (en) | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
US4856188A (en) | 1984-10-12 | 1989-08-15 | Drug Delivery Systems Inc. | Method for making disposable and/or replenishable transdermal drug applicators |
GB2142822B (en) | 1983-06-29 | 1987-02-11 | Alec Stanley Walter Shaw | Nicotine lozenges |
GB8317576D0 (en) | 1983-06-29 | 1983-08-03 | Shaw A S W | Consumer tobacco products |
US5865786A (en) | 1983-08-18 | 1999-02-02 | Drug Delivery Systems, Inc. | Programmable control and mounting system for transdermal drug applicator |
US4708716A (en) * | 1983-08-18 | 1987-11-24 | Drug Delivery Systems Inc. | Transdermal drug applicator |
BE899037A (en) | 1984-02-29 | 1984-06-18 | Trenker Ady | Nicotine compsn. to help people to stop smoking - is a tablet for sucking, which contains nicotine or its water-soluble acid salt |
US4920989A (en) | 1985-04-25 | 1990-05-01 | Regents Of The University Of California | Method and apparatus for aiding in the reduction of incidence of tobacco smoking |
US4953572A (en) | 1985-04-25 | 1990-09-04 | Rose Jed E | Method and apparatus for aiding in the reduction of incidence of tobacco smoking |
ATE80048T1 (en) | 1985-06-10 | 1992-09-15 | Drug Delivery Systems Inc | PROGRAMMABLE CONTROL AND CONSTRUCTION SYSTEM OF A TRANSDERMIC DRUG DELIVERY DEVICE. |
US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US4853854A (en) | 1985-12-26 | 1989-08-01 | Health Innovations, Inc. | Human behavior modification which establishes and generates a user adaptive withdrawal schedule |
US4772263A (en) | 1986-02-03 | 1988-09-20 | Regents Of The University Of Minnesota | Spring driven infusion pump |
DE3645036A1 (en) | 1986-11-18 | 1989-01-05 | Forschungsgesellschaft Rauchen | Nicotine-containing composition |
US4917676A (en) | 1986-11-20 | 1990-04-17 | Ciba-Geigy Corporation | User-activated transdermal therapeutic system |
AT391998B (en) | 1987-02-02 | 1990-12-27 | Falko Dr Skrabal | Device for determining the concentration of at least one medicinal substance in living organisms |
US5049387A (en) | 1987-03-09 | 1991-09-17 | Alza Corporation | Inducing skin tolerance to a sensitizing drug |
US5000956A (en) | 1987-03-09 | 1991-03-19 | Alza Corporation | Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug |
US5013293A (en) | 1987-05-28 | 1991-05-07 | Drug Delivery Systems Inc. | Pulsating transdermal drug delivery system |
US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
US5388571A (en) | 1987-07-17 | 1995-02-14 | Roberts; Josephine A. | Positive-pressure ventilator system with controlled access for nebulizer component servicing |
US5073380A (en) | 1987-07-27 | 1991-12-17 | Mcneil-Ppc, Inc. | Oral sustained release pharmaceutical formulation and process |
ES2074441T3 (en) | 1987-10-05 | 1995-09-16 | Yamanouchi Pharma Co Ltd | HETERO CYCLIC SPIRAL COMPOUNDS AND THEIR PREPARATION. |
JPH01265021A (en) | 1987-10-29 | 1989-10-23 | Hercon Lab Corp | Article for discharging and supplying composition containing pharmacologically active substance to animal tissue in controllable manner |
US4917895A (en) | 1987-11-02 | 1990-04-17 | Alza Corporation | Transdermal drug delivery device |
US4885154A (en) | 1988-03-01 | 1989-12-05 | Alza Corporation | Method for reducing sensitization or irritation in transdermal drug delivery and means therefor |
US5472946A (en) | 1988-04-08 | 1995-12-05 | Peck; James V. | Transdermal penetration enhancers |
US5364630A (en) | 1988-06-14 | 1994-11-15 | Alza Corporation | Subsaturated nicotine transdermal therapeutic system |
US5028428A (en) | 1988-08-09 | 1991-07-02 | Estee Lauder Inc. | Anti-irritant and desensitizing compositions and methods of their use |
US4952928A (en) | 1988-08-29 | 1990-08-28 | B. I. Incorporated | Adaptable electronic monitoring and identification system |
US5496266A (en) * | 1990-04-30 | 1996-03-05 | Alza Corporation | Device and method of iontophoretic drug delivery |
US5236714A (en) | 1988-11-01 | 1993-08-17 | Alza Corporation | Abusable substance dosage form having reduced abuse potential |
US5248501A (en) | 1988-11-22 | 1993-09-28 | Parnell Pharmaceuticals | Drug delivery systems containing eriodictyon fluid extract as an excipient, and methods and compositions associated therewith |
IE62662B1 (en) | 1989-01-06 | 1995-02-22 | Elan Corp Plc | Use of nicotine in the treatment of conditions susceptible to said treatment |
JP2638635B2 (en) | 1989-01-31 | 1997-08-06 | 積水化学工業株式会社 | Transdermal formulation |
JPH02208813A (en) | 1989-02-09 | 1990-08-20 | Fuji Photo Film Co Ltd | Thin film magnetic head |
US4908213A (en) | 1989-02-21 | 1990-03-13 | Schering Corporation | Transdermal delivery of nicotine |
GB2230439A (en) | 1989-04-20 | 1990-10-24 | Alec Stanley Walter Shaw | Nicotine lozenges |
US5262165A (en) | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
US5525351A (en) | 1989-11-07 | 1996-06-11 | Dam; Anders | Nicotine containing stimulant unit |
US5512306A (en) | 1992-06-19 | 1996-04-30 | Pharmica Ab | Smoking substitute |
US5149719A (en) | 1990-04-27 | 1992-09-22 | Minnesota Mining And Manufacturing Company | Composition for transdermal penetration of medicaments |
US5130139A (en) | 1990-07-06 | 1992-07-14 | Alza Corporation | Reduction or prevention of skin irritation by drugs |
US5120545A (en) | 1990-08-03 | 1992-06-09 | Alza Corporation | Reduction or prevention of sensitization to drugs |
US5242941A (en) * | 1990-12-04 | 1993-09-07 | State Of Oregon | Methods of treating circadian rhythm disorders |
US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
US5232704A (en) | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
US5221254A (en) | 1991-04-02 | 1993-06-22 | Alza Corporation | Method for reducing sensation in iontophoretic drug delivery |
ES2153360T3 (en) | 1991-05-29 | 2001-03-01 | Abbott Lab | ISOXAZOL AND ISOTIAZOL COMPOUNDS THAT IMPROVE REASONING FUNCTIONS. |
US5149538A (en) | 1991-06-14 | 1992-09-22 | Warner-Lambert Company | Misuse-resistive transdermal opioid dosage form |
US5464387A (en) | 1991-07-24 | 1995-11-07 | Alza Corporation | Transdermal delivery device |
US5273755A (en) | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset |
US5273756A (en) | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
US5352456A (en) * | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
DE4138352C2 (en) * | 1991-11-21 | 2000-03-16 | Stuertz Maschbau | Method and device for producing rectangular frames |
US5304739A (en) | 1991-12-19 | 1994-04-19 | Klug Reja B | High energy coaxial cable for use in pulsed high energy systems |
GB9200047D0 (en) | 1992-01-03 | 1992-02-26 | Univ Alberta | Nicotine-containing nasal spray |
US6436078B1 (en) | 1994-12-06 | 2002-08-20 | Pal Svedman | Transdermal perfusion of fluids |
ATE192646T1 (en) * | 1992-01-21 | 2000-05-15 | Howard Alliger | USE OF A MIXTURE OF SUBSTANCES CONTAINING ALPHA HYDROXY ORGANIC ACID FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF MINOR ORAL ULCERS |
IL104365A0 (en) | 1992-01-31 | 1993-05-13 | Gensia Pharma | Method and apparatus for closed loop drug delivery |
CH686816A5 (en) | 1992-02-04 | 1996-07-15 | Asulab Ag | Means for delivering a drug. |
US5212188A (en) | 1992-03-02 | 1993-05-18 | R. J. Reynolds Tabacco Company | Method for treatment of neurodegenerative diseases |
US5242934A (en) | 1992-03-02 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5242935A (en) | 1992-03-06 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5405614A (en) | 1992-04-08 | 1995-04-11 | International Medical Associates, Inc. | Electronic transdermal drug delivery system |
US5756117A (en) | 1992-04-08 | 1998-05-26 | International Medical Asscociates, Inc. | Multidose transdermal drug delivery system |
US5227391A (en) | 1992-04-10 | 1993-07-13 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5232933A (en) | 1992-05-21 | 1993-08-03 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5310404A (en) | 1992-06-01 | 1994-05-10 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
CA2072040C (en) | 1992-06-23 | 2002-06-11 | Charles Borg | Method and device to facilitate the cognitive development of alternative response behaviour |
US5501697A (en) | 1992-06-23 | 1996-03-26 | Fisher; Gary R. | Treatment device to aid in long-term cessation of smoking |
US5248690A (en) | 1992-07-07 | 1993-09-28 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5252604A (en) | 1992-07-10 | 1993-10-12 | Hoffmann-La Roche Inc. | Compositions of retinoic acids and tocopherol for prevention of dermatitis |
EP0656771A4 (en) | 1992-08-25 | 1996-07-31 | Cygnus Therapeutic Systems | Printed transdermal drug delivery device. |
IL107184A (en) | 1992-10-09 | 1997-08-14 | Abbott Lab | Heterocyclic ether compounds that enhance cognitive function |
AU5551394A (en) | 1992-11-09 | 1994-06-08 | Pharmetrix Corporation | Combined analgesic delivery methods for pain management |
CA2114968A1 (en) | 1993-02-25 | 1994-08-26 | John Wille | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
US5843979A (en) | 1993-02-25 | 1998-12-01 | Bristol-Myers Squibb Company | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
US5516793A (en) | 1993-04-26 | 1996-05-14 | Avon Products, Inc. | Use of ascorbic acid to reduce irritation of topically applied active ingredients |
US5445609A (en) | 1993-05-28 | 1995-08-29 | Alza Corporation | Electrotransport agent delivery device having a disposable component and a removable liner |
US5451407A (en) | 1993-06-21 | 1995-09-19 | Alza Corporation | Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug |
WO1995003028A1 (en) * | 1993-07-23 | 1995-02-02 | Morris Herstein | Cosmetic, skin-renewal stimulating composition with long-term irritation control |
US5549906A (en) | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
US5377258A (en) | 1993-08-30 | 1994-12-27 | National Medical Research Council | Method and apparatus for an automated and interactive behavioral guidance system |
US5533971A (en) | 1993-09-03 | 1996-07-09 | Alza Corporation | Reduction of skin irritation during electrotransport |
AU662877B3 (en) | 1993-10-21 | 1995-09-14 | Amal Hakim Khalil | Nicotine lozenges |
US5997501A (en) | 1993-11-18 | 1999-12-07 | Elan Corporation, Plc | Intradermal drug delivery device |
DE4400770C1 (en) * | 1994-01-13 | 1995-02-02 | Lohmann Therapie Syst Lts | Plaster containing an active substance for delivery of oestradiol with at least one penetration enhancer, method of producing it and its use |
US5393526A (en) | 1994-02-07 | 1995-02-28 | Elizabeth Arden Company, Division Of Conopco, Inc. | Cosmetic compositions |
AU1958295A (en) * | 1994-04-13 | 1995-11-10 | Novartis Ag | Temporally controlled drug delivery systems |
US6121276A (en) | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
US5876368A (en) | 1994-09-30 | 1999-03-02 | Becton Dickinson And Company | Iontophoretic drug delivery device having improved controller |
US5445823A (en) | 1994-10-20 | 1995-08-29 | The Procter & Gamble Company | Dermatological compositions and method of treatment of skin lesions therewith |
US5505958A (en) * | 1994-10-31 | 1996-04-09 | Algos Pharmaceutical Corporation | Transdermal drug delivery device and method for its manufacture |
US5703100A (en) | 1994-11-10 | 1997-12-30 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5686100A (en) | 1994-11-22 | 1997-11-11 | E.R. Squibb & Sons, Inc. | Prophylactic and therapeutic treatment of skin sensitization and irritation |
US5618557A (en) | 1994-11-22 | 1997-04-08 | E.R. Squibb & Sons, Inc. | Prophylactic treatment of allergic contact dermatitis |
US5697896A (en) | 1994-12-08 | 1997-12-16 | Alza Corporation | Electrotransport delivery device |
DE4444238A1 (en) | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Cosmetic or dermatological drug combinations of cinnamic acid derivatives and flavone glycosides |
FR2728793A1 (en) | 1994-12-28 | 1996-07-05 | Oreal | Compsns. for treating sensitive skin |
US5562607A (en) | 1995-01-18 | 1996-10-08 | Alza Corporation | Electrotransport device having reusable controller power saver |
US5879322A (en) * | 1995-03-24 | 1999-03-09 | Alza Corporation | Self-contained transdermal drug delivery device |
AU5543196A (en) | 1995-04-12 | 1996-10-30 | Robert B. Hopp | Skin patch for use in contact immunotherapy |
US5601839A (en) | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
US5882676A (en) | 1995-05-26 | 1999-03-16 | Alza Corporation | Skin permeation enhancer compositions using acyl lactylates |
IL118279A (en) | 1995-06-07 | 2006-10-05 | Abbott Lab | 3 - pyridyloxy (or thio) alkyl heterocyclic compounds, pharmaceutical compositions containing them and their uses in the preparation of medicaments for controlling chemical synaptic transmission |
US6093419A (en) | 1995-06-07 | 2000-07-25 | Lectec Corporation | Compliance verification method and device in compulsory drug administration |
US6245347B1 (en) | 1995-07-28 | 2001-06-12 | Zars, Inc. | Methods and apparatus for improved administration of pharmaceutically active compounds |
AU7083596A (en) | 1995-09-22 | 1997-04-09 | Novo Nordisk A/S | Novel substituted azacyclic or azabicyclic compounds |
WO1997011073A1 (en) | 1995-09-22 | 1997-03-27 | Novo Nordisk A/S | Novel substituted azacyclic or azabicyclic compounds |
CA2233197A1 (en) | 1995-09-28 | 1997-04-03 | Becton, Dickinson And Company | Iontophoretic drug delivery system, including reusable device |
US5688232A (en) | 1995-09-28 | 1997-11-18 | Becton Dickinson And Company | Iontophoretic drug delivery device having an improved controller |
JP3969741B2 (en) | 1995-11-17 | 2007-09-05 | マーク アンド カンパニー インコーポレイテッド | Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
AU1058797A (en) | 1995-11-22 | 1997-06-11 | Bristol-Myers Squibb Company | Treatment with calcium channel blockers for drug-induced hypersensitivity |
US8092224B2 (en) | 1995-11-22 | 2012-01-10 | James A. Jorasch | Systems and methods for improved health care compliance |
ZA9610374B (en) | 1995-12-11 | 1997-06-23 | Elan Med Tech | Cartridge-based drug delivery device |
US5846983A (en) | 1996-02-09 | 1998-12-08 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
US5733269A (en) | 1996-03-15 | 1998-03-31 | Fuisz Technologies Ltd. | Method and kit for positioning transdermal delivery system |
WO1997034605A1 (en) | 1996-03-21 | 1997-09-25 | Mayo Foundation For Medical Education And Research | Use of nicotine to treat liver disease |
US6271240B1 (en) | 1996-05-06 | 2001-08-07 | David Lew Simon | Methods for improved regulation of endogenous dopamine in prolonged treatment of opioid addicted individuals |
US5785688A (en) * | 1996-05-07 | 1998-07-28 | Ceramatec, Inc. | Fluid delivery apparatus and method |
PL187242B1 (en) | 1996-05-13 | 2004-06-30 | Novartis Consumer Health Sa | Buccal delivery system |
US5629325A (en) | 1996-06-06 | 1997-05-13 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
US5716987A (en) | 1996-06-21 | 1998-02-10 | Bristol-Myers Squibb Company | Prophylactic and therapeutic treatment of skin sensitization and irritation |
GB9614902D0 (en) | 1996-07-16 | 1996-09-04 | Rhodes John | Sustained release composition |
US5788671A (en) | 1996-08-14 | 1998-08-04 | Sims Deltec, Inc. | Reusable cassette housings and methods |
WO1998007364A1 (en) | 1996-08-16 | 1998-02-26 | Roche Diagnostics Gmbh | Monitoring system for the regular intake of a medicament |
US5972389A (en) | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
US5797867A (en) | 1996-09-27 | 1998-08-25 | Becton Dickinson And Company | Iontophoretic drug delivery system, including method for activating same for attachment to patient |
US5919156A (en) | 1996-09-27 | 1999-07-06 | Becton, Dickinson And Company | Iontophoretic drug delivery system, including unit for dispensing patches |
US6746688B1 (en) | 1996-10-13 | 2004-06-08 | Neuroderm Ltd. | Apparatus for the transdermal treatment of Parkinson's disease |
US5800832A (en) | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
SK284825B6 (en) | 1996-11-21 | 2005-12-01 | Laboratoires D'hygiene Et De Dietetique (L.H.D.) | Miniature valve for filling the reservoir of an apparatus for the transdermal administration of medicine |
DE19650115C1 (en) | 1996-12-03 | 1998-07-02 | Fraunhofer Ges Forschung | Medication dosing device |
US5908301A (en) | 1996-12-05 | 1999-06-01 | Lutz; Raymond | Method and device for modifying behavior |
US8734339B2 (en) | 1996-12-16 | 2014-05-27 | Ip Holdings, Inc. | Electronic skin patch for real time monitoring of cardiac activity and personal health management |
US6019997A (en) | 1997-01-09 | 2000-02-01 | Minnesota Mining And Manufacturing | Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents |
US6018679A (en) | 1997-01-29 | 2000-01-25 | Novartis Finance Corp. | Iontophoretic transdermal delivery and control of adverse side-effects |
US6020335A (en) | 1997-02-06 | 2000-02-01 | Pfizer Inc | (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
US5860957A (en) | 1997-02-07 | 1999-01-19 | Sarcos, Inc. | Multipathway electronically-controlled drug delivery system |
US5861423A (en) | 1997-02-21 | 1999-01-19 | Caldwell; William Scott | Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
DE69826113T2 (en) | 1997-03-11 | 2005-01-20 | Arakis Ltd., Saffron Walden | R AND S-ENANTIOMER SEPARATED DOSAGE FORMS |
FR2761072B1 (en) | 1997-03-20 | 1999-04-23 | Synthelabo | 2,3-DIHYDROFURO [3,2-B] PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
US5977131A (en) | 1997-04-09 | 1999-11-02 | Pfizer Inc. | Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
WO1998046093A1 (en) | 1997-04-14 | 1998-10-22 | Robert Lindburg | Smoking control device |
US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
DE69810107T2 (en) | 1997-05-30 | 2003-08-21 | Neurosearch As Ballerup | AZACYCLOOKTAN AND HEPTAN DERIVATIVES, THEIR PRODUCTION AND THEIR THERAPEUTIC USE |
DK0984966T3 (en) | 1997-05-30 | 2003-05-05 | Neurosearch As | 9-azabicyclo [3.3.1] non-2-one derivatives which are cholinergic ligands on nicotine ACh receptors |
NZ500643A (en) | 1997-05-30 | 2001-12-21 | Neurosearch As | Spiro-quinuclidine derivatives and their use in treating conditions responsive to nicotinic ACh receptor modulators |
KR100589872B1 (en) | 1997-05-30 | 2006-06-15 | 뉴로서치 에이/에스 | 8-Azabicyclo3,2,1oct-2-ene derivatives and the preparation thereof |
ATE302597T1 (en) | 1997-06-06 | 2005-09-15 | Depomed Inc | STOMACH-RESIDENT ORAL DOSAGE FORMS OF WATER-SOLUBLE DRUGS WITH CONTROLLED RELEASE |
FR2765874B1 (en) | 1997-07-09 | 1999-08-13 | Synthelabo | 6-PYRROLIDIN-2-YLPYRINDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
AR013184A1 (en) | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | SPYROZOBICYCLIC HETERO CYCLIC AMINES, PHARMACEUTICAL COMPOSITION, USE OF SUCH AMINES TO PREPARE MEDICINES AND METHOD OF TREATMENT OR PROPHYLAXIS |
US6420622B1 (en) | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
ES2234139T3 (en) | 1997-08-11 | 2005-06-16 | Alza Corporation | DOSAGE FORM OF AN ACTIVE PROLONGED RELEASE AGENT ADAPTED FOR GASTRIC RETENTION. |
US6034079A (en) | 1997-08-11 | 2000-03-07 | University Of South Florida | Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
DE19738855C2 (en) | 1997-09-05 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermal therapeutic system with adhesive reservoir layer and unidirectional elastic back layer |
US5786888A (en) * | 1997-09-16 | 1998-07-28 | Trw Inc. | Pulsed radiation classifier and related method |
US6660295B2 (en) | 1997-09-30 | 2003-12-09 | Alza Corporation | Transdermal drug delivery device package with improved drug stability |
US7011843B2 (en) | 1997-10-01 | 2006-03-14 | Lts Lohmann-Therapie Systeme Ag | Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system |
US5879292A (en) | 1997-10-09 | 1999-03-09 | Edward A. Sternberg | Bandage including data acquisition components |
RU2205179C2 (en) | 1997-10-27 | 2003-05-27 | НьюроСёрч А/С | Homopiperazine derivative and pharmaceutical composition |
US6162214A (en) | 1997-10-30 | 2000-12-19 | Eclipse Surgical Technologies, Inc. | Corning device for myocardial revascularization |
AU747419B2 (en) | 1997-11-05 | 2002-05-16 | Neurosearch A/S | Azaring-ether derivatives and their use as nicotinic ACH receptor modulators |
CN1172674C (en) | 1997-11-10 | 2004-10-27 | 赛勒吉药物股份有限公司 | Penetration enhancing and irritation reducing systems |
US6374136B1 (en) * | 1997-12-22 | 2002-04-16 | Alza Corporation | Anhydrous drug reservoir for electrolytic transdermal delivery device |
EP1041975B1 (en) | 1997-12-22 | 2002-09-04 | Alza Corporation | Rate controlling membranes for controlled drug delivery devices |
US6059736A (en) | 1998-02-24 | 2000-05-09 | Tapper; Robert | Sensor controlled analysis and therapeutic delivery system |
CA2231968A1 (en) | 1998-03-11 | 1999-09-11 | Smoke-Stop, A Partnership Consisting Of Art Slutsky | Method of producing a nicotine medicament |
EP1064035B1 (en) * | 1998-03-23 | 2003-11-26 | ELAN CORPORATION, Plc | Drug delivery device |
US5945123A (en) * | 1998-04-02 | 1999-08-31 | K-V Pharmaceutical Company | Maximizing effectiveness of substances used to improve health and well being |
US20040062802A1 (en) | 1998-04-02 | 2004-04-01 | Hermelin Victor M. | Maximizing effectiveness of substances used to improve health and well being |
US6057446A (en) | 1998-04-02 | 2000-05-02 | Crooks; Peter Anthony | Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds |
EP0955301A3 (en) | 1998-04-27 | 2001-04-18 | Pfizer Products Inc. | 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors |
US6211194B1 (en) | 1998-04-30 | 2001-04-03 | Duke University | Solution containing nicotine |
US6232316B1 (en) | 1998-06-16 | 2001-05-15 | Targacept, Inc. | Methods for treatment of CNS disorders |
US5967789A (en) | 1998-07-30 | 1999-10-19 | Smoke Stoppers International, Inc. | Method and system for stopping or modifying undesirable health-related behavior habits or maintaining desirable health-related behavior habits |
US6365182B1 (en) | 1998-08-12 | 2002-04-02 | Cima Labs Inc. | Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet |
US6368625B1 (en) | 1998-08-12 | 2002-04-09 | Cima Labs Inc. | Orally disintegrable tablet forming a viscous slurry |
JP2002523413A (en) | 1998-08-25 | 2002-07-30 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | Pyridyl ethers and thioethers as nicotinic acetylcholine receptor ligands and their therapeutic use |
US6165165A (en) * | 1998-10-02 | 2000-12-26 | Genx International, Inc. | Embryo-implanting catheter assembly and method for making the same |
US6262124B1 (en) | 1998-10-22 | 2001-07-17 | Gary Maurice Dull | Pharmaceutical compositions and methods for use |
US6211296B1 (en) * | 1998-11-05 | 2001-04-03 | The B. F. Goodrich Company | Hydrogels containing substances |
CN1231483C (en) | 1998-11-27 | 2005-12-14 | 神经研究公司 | 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives |
FR2786769B1 (en) | 1998-12-04 | 2002-10-25 | Synthelabo | 2,5-DIAZABICYCLO [2.2.1] HEPTANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
FR2786770B1 (en) | 1998-12-04 | 2001-01-19 | Synthelabo | NONANE 1,4-DIAZABICYCLO [3.2.2.] DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
JP2002532393A (en) | 1998-12-16 | 2002-10-02 | ユニヴァーシティー オブ サウス フロリダ | Exo-R-mecamylamine formulations and their use in therapy |
KR100383252B1 (en) | 1998-12-17 | 2003-07-16 | 주식회사 삼양사 | Transdermal Dosage Compositions Containing Buprenoline and Patches Comprising the Same |
CZ20012716A3 (en) | 1999-01-29 | 2001-11-14 | Abbott Laboratories | Diazabicyclic derivatives functioning as ligands of acetylcholine nicotine receptor |
US6583160B2 (en) | 1999-04-14 | 2003-06-24 | Steve Smith | Nicotine therapy method and oral carrier for assuaging tobacco-addiction |
US6454708B1 (en) | 1999-04-15 | 2002-09-24 | Nexan Limited | Portable remote patient telemonitoring system using a memory card or smart card |
US6416471B1 (en) | 1999-04-15 | 2002-07-09 | Nexan Limited | Portable remote patient telemonitoring system |
DE60003911T2 (en) | 1999-04-26 | 2004-05-27 | Neurosearch A/S | HETEROARYL-DIAZACYCLOALKANE, THEIR PRODUCTION AND USE |
EP1177198B1 (en) | 1999-04-29 | 2002-11-20 | Dow Global Technologies Inc. | Bis(n,n-dihydrocarbylamino)- substituted cyclopentadienes and metal complexes thereof |
US6689380B1 (en) | 1999-05-17 | 2004-02-10 | Kevin S. Marchitto | Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy |
DE19925613A1 (en) * | 1999-06-04 | 2000-12-07 | Lohmann Therapie Syst Lts | Composite laminate and process for its manufacture |
CA2376128C (en) | 1999-06-04 | 2009-01-06 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
US6567785B2 (en) | 1999-06-19 | 2003-05-20 | John Richard Clendenon | Electronic behavior modification reminder system and method |
DE19958554C2 (en) | 1999-07-02 | 2002-06-13 | Lohmann Therapie Syst Lts | Microreservoir system based on polysiloxanes and ambiphilic solvents and their manufacture |
US20040229908A1 (en) | 1999-07-13 | 2004-11-18 | Jodi Nelson | Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias |
US20080138399A1 (en) | 1999-07-16 | 2008-06-12 | Aradigm Corporation | Dual release nicotine formulations, and systems and methods for their use |
WO2001005459A1 (en) | 1999-07-16 | 2001-01-25 | Aradigm Corporation | System for effecting smoke cessation |
US8256433B2 (en) | 1999-07-16 | 2012-09-04 | Aradigm Corporation | Systems and methods for effecting cessation of tobacco use |
US20080138294A1 (en) | 1999-07-16 | 2008-06-12 | Igor Gonda | Systems and methods for effecting cessation of tobacco use |
US20080138398A1 (en) | 1999-07-16 | 2008-06-12 | Aradigm Corporation | Dual release nicotine formulations, and systems and methods for their use |
US6799576B2 (en) | 1999-07-16 | 2004-10-05 | Aradigm Corporation | System for effecting smoking cessation |
US8188043B2 (en) | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
DE60018582T2 (en) | 1999-08-18 | 2006-01-19 | Microchips, Inc., Bedford | THERMALLY ACTIVATABLE MICROCHIP AS CHARGING DEVICE FOR CHEMICALS |
US7376700B1 (en) | 1999-08-23 | 2008-05-20 | Wellcoaches Corporation | Personal coaching system for clients with ongoing concerns such as weight loss |
FR2798065B1 (en) | 1999-09-02 | 2003-09-05 | Assist Publ Hopitaux De Paris | USE OF NICOTINE OR DERIVATIVES THEREOF IN A MEDICAMENT FOR THE TREATMENT OF NEUROLOGICAL DISEASES, ESPECIALLY PARKINSON'S DISEASE |
KR20010036685A (en) | 1999-10-11 | 2001-05-07 | 김윤 | Transdermal fentanyl delivery matrix system |
SE9903998D0 (en) | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
EP1231900A1 (en) | 1999-11-23 | 2002-08-21 | The Robert Gordon University | Bilayered buccal tablets comprising nicotine |
US6539250B1 (en) * | 1999-12-15 | 2003-03-25 | David S. Bettinger | Programmable transdermal therapeutic apparatus |
US20020004065A1 (en) * | 2000-01-20 | 2002-01-10 | David Kanios | Compositions and methods to effect the release profile in the transdermal administration of active agents |
US6261595B1 (en) | 2000-02-29 | 2001-07-17 | Zars, Inc. | Transdermal drug patch with attached pocket for controlled heating device |
JP2001261652A (en) | 2000-03-21 | 2001-09-26 | Suntory Ltd | Disubstituted iminoheterocyclic compound |
AU2000258901A1 (en) | 2000-04-06 | 2001-10-23 | Nicholas V. Perricone | Treatment of skin damage using olive oil polyphenols |
US6489025B2 (en) | 2000-04-12 | 2002-12-03 | Showa Denko K.K. | Fine carbon fiber, method for producing the same and electrically conducting material comprising the fine carbon fiber |
US6955821B2 (en) | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
WO2001089571A2 (en) | 2000-05-19 | 2001-11-29 | Sabinsa Corporation | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives |
AU6501201A (en) * | 2000-06-01 | 2001-12-11 | Science Applic Int Corp | Systems and methods for monitoring health and delivering drugs transdermally |
MXPA06002836A (en) | 2000-06-16 | 2006-06-14 | Bodymedia Inc | System for monitoring and managing body weight and other physiological conditions including iterative and personalized planning, intervention and reporting capability. |
AU2001279284A1 (en) | 2000-07-05 | 2002-01-14 | Capricorn Pharma, Inc | Rapid-melt semi-solid compositions, methods of making same and methods of using same |
US6589229B1 (en) | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
JP2002092180A (en) | 2000-09-19 | 2002-03-29 | Hiroko Takahashi | System for supporting abstention from smoking |
EP1330236A2 (en) | 2000-10-12 | 2003-07-30 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
GB0026137D0 (en) | 2000-10-25 | 2000-12-13 | Euro Celtique Sa | Transdermal dosage form |
US6569449B1 (en) | 2000-11-13 | 2003-05-27 | University Of Kentucky Research Foundation | Transdermal delivery of opioid antagonist prodrugs |
US6682757B1 (en) | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
DE10102817B4 (en) | 2001-01-23 | 2006-01-12 | Lts Lohmann Therapie-Systeme Ag | Device and method for heat pulse-assisted transdermal application of active substances |
DE10103158A1 (en) | 2001-01-24 | 2002-08-01 | Christian Von Falkenhausen | Device for electricity-assisted introduction of active agents into the skin comprises at least two electrodes which are connected through galvanic conduction of the reservoir of the active agent |
DE10105759C1 (en) | 2001-02-08 | 2001-10-25 | Lohmann Therapie Syst Lts | Electrically and magnetically assisted charge carrier delivery device e.g. for transdermal application of pharmaceuticals, has electrical and magnetic fields applied to charge carrier reservoir layer |
CN1556716A (en) | 2001-02-22 | 2004-12-22 | ���Ͽع�����˾ | Modular infusion device and method |
AU2002255627B2 (en) | 2001-02-27 | 2008-01-17 | The Regents Of The University Of Michigan | Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor |
US20020127256A1 (en) * | 2001-03-01 | 2002-09-12 | Howard Murad | Compositions and methods for treating dermatological disorders |
FR2822377A1 (en) | 2001-03-23 | 2002-09-27 | Oreal | USE OF FIBERS AS ANTI-IRRITANT AGENT IN A COSMETIC OR DERMATOLOGICAL COMPOSITION |
WO2002076401A2 (en) | 2001-03-26 | 2002-10-03 | Dana-Farber Cancer Institute, Inc. | Method of attenuating reactions to skin irritants |
AR033444A1 (en) | 2001-03-26 | 2003-12-17 | Smithkline Beecham Corp | SOLID DOSAGE FORM FOR THE ORAL ADMINISTRATION OF AN ACTIVE NICOTINE COMPOUND, THROUGH THE MUCOSE AND USE OF AN ACTIVE NICOTINE COMPOUND TO PREPARE IT |
CA2381630A1 (en) | 2001-04-23 | 2002-10-23 | Leonard Theodore Meltzer | Method for preventing dyskinesias |
DE60230138D1 (en) | 2001-05-01 | 2009-01-15 | Euro Celtique Sa | PROTECTED FROM MISUSE OF OPIOID-CONTAINING TRANSDERMALE SYSTEMS |
US6723086B2 (en) * | 2001-05-07 | 2004-04-20 | Logiq Wireless Solutions, Inc. | Remote controlled transdermal medication delivery device |
US20040019321A1 (en) | 2001-05-29 | 2004-01-29 | Sage Burton H. | Compensating drug delivery system |
SE0102197D0 (en) | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
US6860731B2 (en) * | 2001-07-09 | 2005-03-01 | Asm Technology Singapore Pte Ltd. | Mold for encapsulating a semiconductor chip |
US7332182B2 (en) | 2001-08-06 | 2008-02-19 | Purdue Pharma L.P. | Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant |
US20030044458A1 (en) | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
US6576269B1 (en) | 2001-09-06 | 2003-06-10 | Alexander Y. Korneyev | Treating open skin lesions using extract of sea buckthorn |
GB0121628D0 (en) | 2001-09-07 | 2001-10-31 | Watmough David J | Improved method and apparatus for transdermal drug delivery |
FR2829644A1 (en) | 2001-09-10 | 2003-03-14 | St Microelectronics Sa | Internet digital word watermarking transmission having symmetrical algorithm authentication key before transmission and authentication key watermarking phase and transmission watermarked words |
US7615234B2 (en) | 2001-09-11 | 2009-11-10 | Glide Pharmaceutical Technologies Limited | Drug delivery technology |
US20060122577A1 (en) | 2001-09-26 | 2006-06-08 | Poulsen Jens U | Modular drug delivery system |
SE0103211D0 (en) | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
US6723077B2 (en) * | 2001-09-28 | 2004-04-20 | Hewlett-Packard Development Company, L.P. | Cutaneous administration system |
US6893655B2 (en) | 2001-10-09 | 2005-05-17 | 3M Innovative Properties Co. | Transdermal delivery devices |
US20030087937A1 (en) | 2001-10-15 | 2003-05-08 | Nils-Olof Lindberg | Nicotine and cocoa powder compositions |
US20030119879A1 (en) | 2001-10-15 | 2003-06-26 | Thomas Landh | Nicotine and chocolate compositions |
TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
US6723340B2 (en) | 2001-10-25 | 2004-04-20 | Depomed, Inc. | Optimal polymer mixtures for gastric retentive tablets |
US7429258B2 (en) | 2001-10-26 | 2008-09-30 | Massachusetts Institute Of Technology | Microneedle transport device |
US20040037879A1 (en) | 2001-11-02 | 2004-02-26 | Adusumilli Prasad S. | Oral controlled release forms useful for reducing or preventing nicotine cravings |
US8329217B2 (en) | 2001-11-06 | 2012-12-11 | Osmotica Kereskedelmi Es Szolgaltato Kft | Dual controlled release dosage form |
CA2466047A1 (en) | 2001-11-16 | 2003-05-22 | Medinnovation Ag | Medical pump device |
US7311693B2 (en) | 2001-11-26 | 2007-12-25 | Nilimedix Ltd. | Drug delivery device and method |
US20040052843A1 (en) | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
SE0104388D0 (en) | 2001-12-27 | 2001-12-27 | Pharmacia Ab | New formulation and use and manufacture thereof |
US6852741B2 (en) | 2001-12-31 | 2005-02-08 | University Of Florida | Compositions and methods for treatment of neurological disorders |
JP2005525147A (en) * | 2002-01-16 | 2005-08-25 | エンカプサレイション システムズ,インコーポレーテッド | Substance delivery device |
WO2003061656A1 (en) | 2002-01-16 | 2003-07-31 | Endo Pharmaceuticals Inc. | Pharmaceutical composition and method for treating disorders of the central nervous system |
US20030159702A1 (en) | 2002-01-21 | 2003-08-28 | Lindell Katarina E.A. | Formulation and use manufacture thereof |
US7004928B2 (en) | 2002-02-08 | 2006-02-28 | Rosedale Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
US20040033253A1 (en) | 2002-02-19 | 2004-02-19 | Ihor Shevchuk | Acyl opioid antagonists |
US6861066B2 (en) * | 2002-03-11 | 2005-03-01 | Health Plus International Inc. | Method for the delivery of a biologically active agent |
AU2003265226A1 (en) | 2002-03-11 | 2003-12-19 | Altea Therapeutics Corporation | Transdermal drug delivery device, method and use |
US20070168501A1 (en) | 2002-03-29 | 2007-07-19 | Cobb Nathan K | Method and system for delivering behavior modification information over a network |
US6780171B2 (en) | 2002-04-02 | 2004-08-24 | Becton, Dickinson And Company | Intradermal delivery device |
TW200404581A (en) | 2002-04-23 | 2004-04-01 | Alza Corp | Transdermal analgesic systems with reduced abuse potential |
AU2003221770A1 (en) | 2002-04-29 | 2003-11-17 | Stephen T. Flock | Controlled release transdermal drug delivery |
US7417013B2 (en) * | 2002-05-01 | 2008-08-26 | Mcneil-Ppc, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
WO2003094900A1 (en) | 2002-05-13 | 2003-11-20 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
US20040166159A1 (en) | 2002-05-29 | 2004-08-26 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa |
US7767698B2 (en) | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
KR101407131B1 (en) | 2002-06-10 | 2014-06-19 | 유로-셀티크 소시에떼 아노뉨 | Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
EP1515701B1 (en) | 2002-06-17 | 2014-09-17 | Inventia Healthcare Private Limited | Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide |
US8586079B2 (en) | 2002-06-21 | 2013-11-19 | Graphic Productions Inc. | Promotional simulation for transdermal patch sampler |
US6975902B2 (en) | 2002-06-28 | 2005-12-13 | Alza Corporation | Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof |
US7196619B2 (en) | 2002-06-29 | 2007-03-27 | Neil Perlman | Habit cessation aide |
NZ537991A (en) | 2002-08-30 | 2007-08-31 | Alza Corp | Embossable and writable multilaminate backing construction |
DE10240165A1 (en) | 2002-08-30 | 2004-03-18 | Disetronic Licensing Ag | Dispensing unit for use in infusion pumps comprises reservoir for infusion liquid fitted with spring-loaded piston, toothed wheel cooperating with locking bar to prevent piston moving |
US20040052851A1 (en) | 2002-09-16 | 2004-03-18 | Graff Allan H. | Modified release oral dosage form |
US20040259816A1 (en) | 2002-10-01 | 2004-12-23 | Pandol Stephen J. | Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof |
US7399401B2 (en) | 2002-10-09 | 2008-07-15 | Abbott Diabetes Care, Inc. | Methods for use in assessing a flow condition of a fluid |
US8999372B2 (en) | 2002-11-14 | 2015-04-07 | Cure Pharmaceutical Corporation | Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use |
DK1803444T3 (en) | 2002-12-20 | 2019-02-25 | Niconovum Ab | PROCEDURE FOR PREPARING A NICOTIC PARTICULATE MATERIAL WITH A CRYSTALLINE CELLULOSE (ESPECIALLY MCC) |
US7887842B2 (en) | 2003-02-07 | 2011-02-15 | Teikoku Pharma Usa, Inc. | Methods of administering a dermatological agent to a subject |
AU2003900769A0 (en) | 2003-02-21 | 2003-03-13 | Francis Paul Galea | Medication and smoking cessation watch |
US20040253249A1 (en) | 2003-04-02 | 2004-12-16 | Rudnic Edward M. | Pulsatile transdermally administered antigens and adjuvants |
US7182955B2 (en) | 2003-04-30 | 2007-02-27 | 3M Innovative Properties Company | Abuse-resistant transdermal dosage form |
SE0301320D0 (en) | 2003-05-06 | 2003-05-06 | Astrazeneca Ab | Positive modulators of nicotinic acetylcholine receptors |
US20050159419A1 (en) | 2003-05-14 | 2005-07-21 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage |
US8021334B2 (en) | 2004-05-30 | 2011-09-20 | Nilimedix Ltd. | Drug delivery device and method |
US7149574B2 (en) | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
US20050048020A1 (en) | 2003-07-07 | 2005-03-03 | Wille John J. | Novel topical delivery system for plant derived anti-irritants |
US7231839B2 (en) * | 2003-08-11 | 2007-06-19 | The Board Of Trustees Of The Leland Stanford Junior University | Electroosmotic micropumps with applications to fluid dispensing and field sampling |
DE10338174A1 (en) | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermal drug formulations with drug combinations for the treatment of Parkinson's disease |
US7282217B1 (en) | 2003-08-29 | 2007-10-16 | Kv Pharmaceutical Company | Rapidly disintegrable tablets |
DE602004019430D1 (en) | 2003-09-08 | 2009-03-26 | Mcneil Ab | NICOTINE FORMULATIONS AND THEIR USE |
US20050113452A1 (en) | 2003-10-20 | 2005-05-26 | Moshe Flashner-Barak | Composition and dosage form for sustained effect of levodopa |
EP1527792A1 (en) | 2003-10-27 | 2005-05-04 | Novo Nordisk A/S | Medical injection device mountable to the skin |
CA2544291C (en) * | 2003-10-27 | 2013-01-08 | University Of Basel | Transdermal drug delivery method and system |
CA2542778C (en) | 2003-10-28 | 2012-05-29 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery composition |
MXPA06005509A (en) | 2003-11-13 | 2007-05-23 | Johnson & Johnson | System and method for transdermal delivery. |
US8589174B2 (en) | 2003-12-16 | 2013-11-19 | Adventium Enterprises | Activity monitoring |
US20050266032A1 (en) | 2003-12-17 | 2005-12-01 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
US20050141346A1 (en) | 2003-12-30 | 2005-06-30 | Rawls David K. | Smoking cessation device |
US20050151110A1 (en) * | 2004-01-14 | 2005-07-14 | Minor Barbara H. | Fluoroether refrigerant compositions and uses thereof |
US7867511B2 (en) | 2004-01-23 | 2011-01-11 | Travanti Pharma Inc. | Abuse potential reduction in abusable substance dosage form |
DE602005013490D1 (en) | 2004-02-23 | 2009-05-07 | Euro Celtique Sa | MISSIBLE TRANSDERMAL DISTRIBUTION DEVICE FOR OPIOIDE, CONTAINING OPIOIDANT AGONIST IN THE FORM OF MICRO BEAMS |
IL160578A (en) | 2004-02-25 | 2013-11-28 | Newvaltech Knowledge Services And Invest Ltd | Remote coaching service and server |
KR101053558B1 (en) | 2004-03-30 | 2011-08-03 | 유로-셀띠끄 소시에떼 아노님 | Tamper resistant dosage form comprising an adsorbent and an adverse agent |
US20050226921A1 (en) | 2004-04-13 | 2005-10-13 | Kortzebom Robert N | Non-invasive analysis and controlled dosage transdermal active patch |
DE102004019916A1 (en) | 2004-04-21 | 2005-11-17 | Grünenthal GmbH | Anti-abuse drug-containing patch |
DE102004022678A1 (en) | 2004-05-05 | 2005-12-15 | Humboldt-Universität Zu Berlin | Method for controlling a volume flow of a liquid in an osmotic micropump and osmotic micropump |
CN1332667C (en) | 2004-05-26 | 2007-08-22 | 中国科学院生物物理研究所 | Compound preparation for resisting Parkinson's disease |
US7019622B2 (en) | 2004-05-27 | 2006-03-28 | Research In Motion Limited | Handheld electronic device including vibrator having different vibration intensities and method for vibrating a handheld electronic device |
US8690865B2 (en) | 2004-05-28 | 2014-04-08 | Georgia Tech Research Corporation | Methods and devices for thermal treatment |
US7537590B2 (en) | 2004-07-30 | 2009-05-26 | Microchips, Inc. | Multi-reservoir device for transdermal drug delivery and sensing |
JPWO2006016647A1 (en) | 2004-08-12 | 2008-05-01 | 久光製薬株式会社 | Transdermal drug administration device with microneedle |
DE102004044578A1 (en) | 2004-09-13 | 2006-03-30 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with an adhesive layer, method for siliconizing a backing layer of the system and use of the backing layer |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
EP1802258A4 (en) | 2004-09-13 | 2015-09-23 | Chrono Therapeutics Inc | Biosynchronous transdermal drug delivery |
US8343538B2 (en) | 2004-10-08 | 2013-01-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems |
MX2007004315A (en) | 2004-10-08 | 2008-03-11 | Noven Pharma | Transdermal drug delivery device including an occlusive backing. |
CN101160088B (en) | 2004-10-29 | 2010-04-28 | 杨章民 | Body temperature, respiration, heart sound, deglutition monitoring and medical treatment inquiry unit |
US8999356B1 (en) | 2004-12-03 | 2015-04-07 | Omp, Inc. | Drug delivery system |
CA2591092A1 (en) | 2004-12-17 | 2006-06-22 | Alza Corporation | Temperature modulation of transdermal drug delivery |
DE602005019094D1 (en) | 2004-12-22 | 2010-03-11 | Memory Pharmaceutical Corp | NICOTINE ALPHA-7 RECEPTOR LIGANDS AGAINST DISEASES OF THE CNS |
NZ560516A (en) | 2005-02-01 | 2010-12-24 | Intelliject Inc | A delivery system where a medicant is automatically delivered on activation as well as a recorded instruction |
US8231573B2 (en) | 2005-02-01 | 2012-07-31 | Intelliject, Inc. | Medicament delivery device having an electronic circuit system |
US20060188859A1 (en) | 2005-02-22 | 2006-08-24 | Haim Yakobi | Method and system for computer implemented personal counseling |
US20070042026A1 (en) | 2005-03-17 | 2007-02-22 | Wille John J | Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions |
US8029927B2 (en) | 2005-03-22 | 2011-10-04 | Blue Spark Technologies, Inc. | Thin printable electrochemical cell utilizing a “picture frame” and methods of making the same |
US7641649B2 (en) | 2005-05-06 | 2010-01-05 | Medtronic Minimed, Inc. | Reservoir support and method for infusion device |
US8722233B2 (en) | 2005-05-06 | 2014-05-13 | Blue Spark Technologies, Inc. | RFID antenna-battery assembly and the method to make the same |
US8688189B2 (en) | 2005-05-17 | 2014-04-01 | Adnan Shennib | Programmable ECG sensor patch |
WO2006127905A2 (en) | 2005-05-24 | 2006-11-30 | Chrono Therapeutics, Inc. | Portable drug delivery device |
WO2007013975A2 (en) | 2005-07-20 | 2007-02-01 | Pharmorx Inc. | Composition containing an opioid agonist and a partial opioid agonist, preferably buprenorphine , for controlling abuse of medications |
US9687186B2 (en) | 2005-07-21 | 2017-06-27 | Steadymed Ltd. | Drug delivery device |
US8566121B2 (en) | 2005-08-29 | 2013-10-22 | Narayanan Ramasubramanian | Personalized medical adherence management system |
US20070086275A1 (en) | 2005-10-18 | 2007-04-19 | Robinson Robert J | Electronic reminder device |
JP4355722B2 (en) | 2005-11-17 | 2009-11-04 | セイコーエプソン株式会社 | Fluid transport device |
US7988660B2 (en) | 2005-12-20 | 2011-08-02 | Eli Lilly And Company | Needle-free injection device |
US20070149952A1 (en) | 2005-12-28 | 2007-06-28 | Mike Bland | Systems and methods for characterizing a patient's propensity for a neurological event and for communicating with a pharmacological agent dispenser |
EP1815919A1 (en) * | 2006-02-03 | 2007-08-08 | Uponor Innovation Ab | Making an elongated product |
EP2086317A4 (en) | 2006-12-01 | 2010-03-03 | Aradigm Corp | Nicotine formulations, kits and systems and methods for their use |
EP2125075A2 (en) | 2007-01-22 | 2009-12-02 | Intelliject, Inc. | Medical injector with compliance tracking and monitoring |
ES2521494T3 (en) | 2007-04-02 | 2014-11-12 | Parkinson's Institute | Methods and compositions for reducing the side effects of therapeutic treatments |
US20180110768A1 (en) | 2007-04-02 | 2018-04-26 | Parkinson's Institute | Methods and compositions for reduction of side effects of therapeutic treatments |
CA2841785A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
US20140207047A1 (en) | 2013-01-22 | 2014-07-24 | Chrono Therapeutics, Inc. | Transdermal drug delivery system and method |
US10105487B2 (en) | 2013-01-24 | 2018-10-23 | Chrono Therapeutics Inc. | Optimized bio-synchronous bioactive agent delivery system |
AU2016211330A1 (en) | 2015-01-28 | 2017-08-03 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
US10679516B2 (en) | 2015-03-12 | 2020-06-09 | Morningside Venture Investments Limited | Craving input and support system |
WO2018064377A1 (en) | 2016-09-28 | 2018-04-05 | Chrono Therapeutics Inc. | Transdermal drug delivery device for delivering opioids |
AU2017373857A1 (en) | 2016-12-05 | 2019-06-13 | Morningside Venture Investments Limited | Transdermal drug delivery devices and methods |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
WO2018148746A1 (en) | 2017-02-13 | 2018-08-16 | Chrono Therapuetics Inc. | Transdermal drug delivery devices and methods |
EP3801732A4 (en) | 2018-05-29 | 2022-04-27 | Morningside Venture Investments Limited | Drug delivery methods and systems |
-
2005
- 2005-09-13 EP EP05796698.8A patent/EP1802258A4/en not_active Withdrawn
- 2005-09-13 JP JP2007531458A patent/JP5254616B2/en active Active
- 2005-09-13 US US11/162,525 patent/US7780981B2/en active Active
- 2005-09-13 CA CA2580329A patent/CA2580329C/en active Active
- 2005-09-13 US US11/162,517 patent/US20070191815A1/en not_active Abandoned
- 2005-09-13 WO PCT/US2005/032672 patent/WO2006031856A2/en active Application Filing
- 2005-09-13 AU AU2005284908A patent/AU2005284908B2/en not_active Ceased
-
2010
- 2010-07-13 US US12/835,693 patent/US20100280432A1/en not_active Abandoned
-
2014
- 2014-01-23 US US14/162,156 patent/US20140200525A1/en not_active Abandoned
-
2015
- 2015-06-22 US US14/746,689 patent/US9555226B2/en active Active
- 2015-06-22 US US14/746,704 patent/US9555227B2/en active Active
-
2016
- 2016-12-20 US US15/385,665 patent/US20170100573A1/en not_active Abandoned
- 2016-12-20 US US15/385,638 patent/US10716764B2/en active Active
-
2020
- 2020-02-24 US US16/799,578 patent/US11471424B2/en active Active
- 2020-07-20 US US16/933,836 patent/US20210169822A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5538503A (en) * | 1993-09-15 | 1996-07-23 | Henley; Julian L. | Programmable apparatus for reducing substance dependency in transdermal drug delivery |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009076363A1 (en) * | 2007-12-10 | 2009-06-18 | Isis Biopolymer Llc | Iontophoretic drug delivery device and software application |
DE102010030502A1 (en) | 2010-06-24 | 2011-12-29 | HSG-IMIT-Institut für Mikro- und Informationstechnologie | Quellstoffaktor and conveyor, in particular for a medicinal active substance |
WO2011161246A2 (en) | 2010-06-24 | 2011-12-29 | Hsg-Imit - Institut Für Mikro- Und Informationstechnologie | Swellable substance actuator and delivery device, in particular for a medicinal active substance |
WO2013136176A1 (en) * | 2012-03-13 | 2013-09-19 | Becton Dickinson France | Injection device having a miniaturized drug delivery portion |
US9844631B2 (en) | 2012-03-13 | 2017-12-19 | Becton Dickinson France | Injection device having a miniaturized drug delivery portion |
US10010676B2 (en) | 2012-03-13 | 2018-07-03 | Becton Dickinson France | Method of manufacture for a miniaturized drug delivery device |
US10080843B2 (en) | 2012-03-13 | 2018-09-25 | Becton Dickinson France | Method of manufacture for a miniaturized drug delivery device |
WO2017019526A2 (en) | 2015-07-24 | 2017-02-02 | Kimberly-Clark Worldwide, Inc. | Methods for better delivery of active agents to tumors |
EP3325080A4 (en) * | 2015-07-24 | 2019-04-17 | Sorrento Therapeutics, Inc. | Methods for better delivery of active agents to tumors |
US10806913B2 (en) | 2015-07-24 | 2020-10-20 | Sorrento Therapeutics, Inc. | Methods for better delivery of active agents to tumors |
EP3925599A1 (en) * | 2015-07-24 | 2021-12-22 | Sorrento Therapeutics, Inc. | Methods for better delivery of active agents to tumors |
Also Published As
Publication number | Publication date |
---|---|
US20070191815A1 (en) | 2007-08-16 |
US20170100572A1 (en) | 2017-04-13 |
US9555227B2 (en) | 2017-01-31 |
EP1802258A2 (en) | 2007-07-04 |
US20060062838A1 (en) | 2006-03-23 |
US11471424B2 (en) | 2022-10-18 |
JP5254616B2 (en) | 2013-08-07 |
US10716764B2 (en) | 2020-07-21 |
US7780981B2 (en) | 2010-08-24 |
US20100280432A1 (en) | 2010-11-04 |
JP2008512215A (en) | 2008-04-24 |
CA2580329C (en) | 2015-01-06 |
WO2006031856A3 (en) | 2006-08-17 |
US20140200525A1 (en) | 2014-07-17 |
US9555226B2 (en) | 2017-01-31 |
US20150283366A1 (en) | 2015-10-08 |
AU2005284908A1 (en) | 2006-03-23 |
AU2005284908B2 (en) | 2011-12-08 |
US20150283367A1 (en) | 2015-10-08 |
CA2580329A1 (en) | 2006-03-23 |
US20210169822A1 (en) | 2021-06-10 |
US20170100573A1 (en) | 2017-04-13 |
US20200330369A1 (en) | 2020-10-22 |
EP1802258A4 (en) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005284908B2 (en) | Biosynchronous transdermal drug delivery | |
US10258778B2 (en) | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like | |
US5415629A (en) | Programmable apparatus for the transdermal delivery of drugs and method | |
AU2007238685B2 (en) | Transdermal methods and systems for the delivery of anti-migraine compounds | |
WO2008054788A9 (en) | Transdermal delivery techniques for drugs, nutraceuticals and other active substances | |
US20140207047A1 (en) | Transdermal drug delivery system and method | |
AU2015203213B2 (en) | Transdermal methods and systems for the delivery of anti-migraine compounds | |
AU2012261753A1 (en) | Transdermal methods and systems for the delivery of anti-migraine compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007531458 Country of ref document: JP Ref document number: 2580329 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005284908 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005796698 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005796698 Country of ref document: EP |